Nisha Bansal1, Jason D Wright, Carmel J Cohen, Thomas J Herzog. 1. Columbia University College of Physicians and Surgeons, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York, NY 10032, USA. nishabansal1@yahoo.com
Abstract
UNLABELLED: THE AIM of the present study was to ascertain the natural history of cervical intraepithelial lesions 1 (CIN 1) and to develop recommendations to optimize follow-up. PATIENTS AND METHODS: Patients referred for colposcopy from January, 1996 to July, 2005 were reviewed. A prospectively maintained database was quarried for demographic, clinical, and pathologic data. RESULTS: The cohort included 1,001 patients with CIN 1. At 6 months, 330 patients (49%) regressed to normal, 305 (45%) had persistent low grade, while 45 (7%) progressed to high grade lesions. At 12 months, of those with negative pathology at 6 months, 200 (80%) remained negative, 42 (16%) demonstrated low grade and 9 (4%) progressed to high grade lesions. Of those with low grade lesions at 6 months, 131 (50%) regressed, 121 (46%) had persistent low grade, and 10 (4%) progressed to high grade lesions. CONCLUSION: Our data demonstrates a low rate of progression for CIN 1, suggesting it may be reasonable to prolong the screening interval in women with CIN 1.
UNLABELLED: THE AIM of the present study was to ascertain the natural history of cervical intraepithelial lesions 1 (CIN 1) and to develop recommendations to optimize follow-up. PATIENTS AND METHODS: Patients referred for colposcopy from January, 1996 to July, 2005 were reviewed. A prospectively maintained database was quarried for demographic, clinical, and pathologic data. RESULTS: The cohort included 1,001 patients with CIN 1. At 6 months, 330 patients (49%) regressed to normal, 305 (45%) had persistent low grade, while 45 (7%) progressed to high grade lesions. At 12 months, of those with negative pathology at 6 months, 200 (80%) remained negative, 42 (16%) demonstrated low grade and 9 (4%) progressed to high grade lesions. Of those with low grade lesions at 6 months, 131 (50%) regressed, 121 (46%) had persistent low grade, and 10 (4%) progressed to high grade lesions. CONCLUSION: Our data demonstrates a low rate of progression for CIN 1, suggesting it may be reasonable to prolong the screening interval in women with CIN 1.
Authors: Gloria Y F Ho; Mark H Einstein; Seymour L Romney; Anna S Kadish; Maria Abadi; Magdy Mikhail; Jayasri Basu; Benjamin Thysen; Laura Reimers; Prabhudas R Palan; Shelly Trim; Nafisseh Soroudi; Robert D Burk Journal: J Low Genit Tract Dis Date: 2011-10 Impact factor: 1.925
Authors: Ayodele Gomih; Jennifer S Smith; Kari E North; Michael G Hudgens; Wendy R Brewster; Zhiqing Huang; David Skaar; Fidel Valea; Rex C Bentley; Adriana C Vidal; Rachel L Maguire; Randy L Jirtle; Susan K Murphy; Cathrine Hoyo Journal: Int J Cancer Date: 2018-03-30 Impact factor: 7.396
Authors: Michael Herfs; Carlos Parra-Herran; Brooke E Howitt; Anna R Laury; Marisa R Nucci; Sarah Feldman; Cynthia A Jimenez; Frank D McKeon; Wa Xian; Christopher P Crum Journal: Am J Surg Pathol Date: 2013-09 Impact factor: 6.394
Authors: Anna Gillio-Tos; Maria da Graça Bicalho; Valentina Fiano; Chiara Grasso; Valentina Tarallo; Laura De Marco; Morena Trevisan; Marinabarbaradesousa Xavier; Renata Slowik; Newton S Carvalho; Carlos A Maestri; Hadriano M Lacerda; Daniela Zugna; Lorenzo Richiardi; Franco Merletti Journal: BMC Cancer Date: 2012-12-24 Impact factor: 4.430
Authors: Mariel Garcia-Chagollan; Luis F Jave-Suarez; Jesse Haramati; Pedro E Sanchez-Hernandez; Adriana Aguilar-Lemarroy; Miriam R Bueno-Topete; Ana L Pereira-Suarez; Mary Fafutis-Morris; Angel Cid-Arregui; Susana del Toro-Arreola Journal: J Biomed Sci Date: 2013-08-16 Impact factor: 8.410